Document is current
Any future updates will be listed below
-
Authors
Siafis, Spyridon https://orcid.org/0000-0001-8264-2039
Çıray, Oğulcan https://orcid.org/0000-0003-2864-613X
Schneider-Thoma, Johannes https://orcid.org/0000-0002-3448-9532
Bighelli, Irene https://orcid.org/0000-0002-5661-5149
Krause, Marc https://orcid.org/0000-0002-6125-1466
Rodolico, Alessandro https://orcid.org/0000-0003-2196-0601
Ceraso, Anna
Deste, Giacomo
Huhn, Maximilian https://orcid.org/0000-0003-4011-1189
Fraguas, David https://orcid.org/0000-0002-7931-2933
Mavridis, Dimitris https://orcid.org/0000-0003-1041-4592
Charman, Tony https://orcid.org/0000-0003-1993-6549
Murphy, Declan G. https://orcid.org/0000-0002-6664-7451
Parellada, Mara
Arango, Celso https://orcid.org/0000-0003-3382-4754
Leucht, Stefan https://orcid.org/0000-0002-4934-4352
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (777394)
Spanish Ministry of Science
Instituto de Salud Carlos III
CIBERSAM
Fundación Familia Alonso
Fundación Alicia Koplowitz
Fundación Mutua Madrileña
- License Information
-
More Information
Article History
Received: 1 April 2020
Accepted: 14 August 2020
First Online: 26 August 2020
Change Date: 8 December 2020
Change Type: Update
Change Details: Open Access Funding note was added to backmatter text of the article. This article has been updated to correct this.
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: In the last 3 years, Stefan Leucht has received honoraria as a consultant/advisor and/or for lectures from LB Pharma, Otsuka, Lundbeck, Boehringer Ingelheim, LTS Lohmann, Janssen, Johnson&Johnson, TEVA, MSD, Sandoz, SanofiAventis, Angelini, Recordati, Sunovion, and Geodon Richter. David Fraguas has been a consultant and/or has received fees from Angelini, Eisai, IE4Lab, Janssen, Lundbeck, and Otsuka. He has also received grant support from Instituto de Salud Carlos III (Spanish Ministry of Science, Innovation and Universities) and from Fundación Alicia Koplowitz. Mara Parellada has received educational honoraria from Otsuka, research grants from FAK and Fundación Mutua Madrileña (FMM), Instituto de Salud Carlos III (Spanish Ministry of Science, Innovation and Universities) and European ERANET and H2020 calls, travel grants from Otsuka and Janssen. Consultant for Exeltis and Servier. Celso Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, Roche, Sage, Sanofi, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. In the last 3 years, Maximilian Huhn has received speakers honoraria from Janssen. Declan Murphy has received consulting fees from Roche. The other authors have nothing to disclose.
